HU215435B - Method for producing substitute for dermal tissue, and biological carrier suitable for cultivating cell cultures - Google Patents

Method for producing substitute for dermal tissue, and biological carrier suitable for cultivating cell cultures

Info

Publication number
HU215435B
HU215435B HU3522/90A HU352290A HU215435B HU 215435 B HU215435 B HU 215435B HU 3522/90 A HU3522/90 A HU 3522/90A HU 352290 A HU352290 A HU 352290A HU 215435 B HU215435 B HU 215435B
Authority
HU
Hungary
Prior art keywords
cell cultures
carrier suitable
dermal tissue
biological carrier
cultivating cell
Prior art date
Application number
HU3522/90A
Other languages
Hungarian (hu)
Other versions
HUT58790A (en
HU903522D0 (en
Inventor
Hervé Broly
Vincent Ronfard
Original Assignee
Centre Regional De Transfusion Sanguine De Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Regional De Transfusion Sanguine De Lille filed Critical Centre Regional De Transfusion Sanguine De Lille
Priority to HU3522/90A priority Critical patent/HU215435B/en
Publication of HU903522D0 publication Critical patent/HU903522D0/en
Publication of HUT58790A publication Critical patent/HUT58790A/en
Publication of HU215435B publication Critical patent/HU215435B/en

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A találmány tárgya eljárás sejttenyészeteknél alkalmazható biőlógiaihőrdőzó előállítására, amelyre jellemző, hőgy grammőnként legalább 0,9g fibrinőgént, 0,03–0,1 g fibrőnektint és legalább 0,1 NE XIII-asfaktőrt tartalmazó plazmafehérje-kőncentrátűmból 100–120 g/mlvégkőncentrációjú vizes szűszpenziót készítünk 1000–10 000 KIU/mlkőncentrációjú aprőtinint tartalmazó vizes őld tban, majd a kapőttszűszpenziót azőnős térfőgatú trőmbin-kalciűmmal keverjük össze, majda keverékhez kívánt esetben sejtősztódást segítő anyagőt és/vagyantibiőtikűmőt és/vagy sebgyógyűlást segítő nyagőt adűnk. ŕField of the Invention The present invention relates to a method for producing a bioprotectant for cell cultures, characterized in that it has an aqueous suspension of 100-120 g / ml of final concentration of plasma protein concentrate containing at least 0.9 g of fibrin gene per gram, 0.03-0.1 g of fibrinectin and at least 0.1 IU of XIII asphalt. prepared in an aqueous beer containing 1000 to 10,000 KIU / pound of quinine, then mix the pellet slurry with primordial spheroidal trinium calcine, if desired, additive material and / or antipyretic and / or wound healing aid is added to the mixture. ŕ

HU3522/90A 1990-06-07 1990-06-07 Method for producing substitute for dermal tissue, and biological carrier suitable for cultivating cell cultures HU215435B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU3522/90A HU215435B (en) 1990-06-07 1990-06-07 Method for producing substitute for dermal tissue, and biological carrier suitable for cultivating cell cultures

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU3522/90A HU215435B (en) 1990-06-07 1990-06-07 Method for producing substitute for dermal tissue, and biological carrier suitable for cultivating cell cultures

Publications (3)

Publication Number Publication Date
HU903522D0 HU903522D0 (en) 1990-10-28
HUT58790A HUT58790A (en) 1992-03-30
HU215435B true HU215435B (en) 1999-04-28

Family

ID=10964382

Family Applications (1)

Application Number Title Priority Date Filing Date
HU3522/90A HU215435B (en) 1990-06-07 1990-06-07 Method for producing substitute for dermal tissue, and biological carrier suitable for cultivating cell cultures

Country Status (1)

Country Link
HU (1) HU215435B (en)

Also Published As

Publication number Publication date
HUT58790A (en) 1992-03-30
HU903522D0 (en) 1990-10-28

Similar Documents

Publication Publication Date Title
DE69535328D1 (en) IN-VITRO GROWTH OF LANGERHANS'SCHEN ISLANDS AND ITS USES
NO993709D0 (en) Stabilized composition comprising fibrinogen
EP0259475A4 (en) Recombinant human endothelial cell growth factor.
NO901852L (en) PROCEDURE FOR PREPARING LIPOSOMES.
DE69034018D1 (en) COMBINED USE OF HYALURONIC ACID AND THERAPEUTIC ACTIVE SUBSTANCES TO IMPROVE THE THERAPEUTIC EFFECT
KR870005647A (en) Stabilized Human Tissue Plasminogen Activator Composition
DK85786A (en) BIOLOGICALLY ACTIVE FRAGMENTS OF HUMAN ANTIHAEMOPHILIC FACTOR AND METHOD OF PRODUCING THEREOF
ATE96167T1 (en) PROCESS FOR CRYSTALLIZATION OF ENZYMES.
ES8800601A1 (en) Solid hydrochloride salt of t-PA
EP0216742A3 (en) Growth factors
EP0233013A3 (en) Modified enzyme
KR890003952A (en) New Tissue Plasminogen Activator
GR3007248T3 (en)
FI20075338A (en) No looping changes to gb350 / 220
FR2563108B1 (en) ANTIACID PHARMACEUTICAL COMPOSITION AND AQUEOUS SUSPENSION CONTAINING THE SAME
ES2013500A6 (en) Variants of plasminogen activators and processes for their production.
FR2506616A1 (en) PREPARATION OF GAMMA-GLOBULIN FOR INTRAVENOUS INJECTION AND MANUFACTURING PROCESS, AND THERAPEUTIC AGENT THUS PRODUCED
Nakagawa et al. Tumor necrosis factor stimulates gelatinase and collagenase production by granulation tissue in culture
AU7379687A (en) A process for obtaining active proteins from a biologically inactive form
HU215435B (en) Method for producing substitute for dermal tissue, and biological carrier suitable for cultivating cell cultures
GR860329B (en) Reagent for the dosage of antibodies against bacteric toxines by hemaglutination method for preparation and application thereof
FR2594845B1 (en) MICROBIOLOGICAL PREPARATION OF THE HUMAN PLASMINOGEN TISSUE ACTIVATOR (T-PA) AND CONVERSION OF THE ENZYME SO OBTAINED IN ITS ACTIVE FORM
ATE191923T1 (en) INTERLEUKINE-6 MUTANT WITH IMPROVED BIOLOGICAL ACTIVITY COMPARED TO WILD-TYPE IL-6
ATE127520T1 (en) PROTEIN WITH TRANSACTIVATION PROPERTY, VECTORS EXPRESSING THIS PROTEIN, CELL LINES AND ITS USES.
ES8702463A1 (en) Absorbent polymer material and its preparation.

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: ETABLISSEMENT FRANçAIS DU SANG, FR

Free format text: FORMER OWNER(S): CENTRE REGIONAL DE TRANSFUSION SANGUINE DE LILLE, FR